PDUFA Dates: February 2027
2 FDA target action dates in February 2027. Each PDUFA date is the FDA's deadline to complete review of a drug application.
Mix: 1 NDA, 1 unspecified. Therapeutic areas: oncology.
Cullinan Therapeutics, Inc. CGEM
Zipalertinib NSCLC with EGFR exon 20 insertion (post-platinum) Oncology
NDA
PALVELLA THERAPEUTICS, INC. PVLA
QTORIN 0